We have located links that may give you full text access.
Differences in cognitions during chest pain of patients with panic disorder and ischemic heart disease.
BACKGROUND: A significant number of patients with chest pains who undergo coronary angiography (20-30%) have normal coronary arteries. Up to 50% of this group are eventually diagnosed as Panic Disorder and most continue to complain of their symptoms, in spite of the normal coronary angiogram. We hypothesized that the cognitions of panic disorder subjects on presentation with chest pain would differ from those of patients suffering from true angina pectoris.
METHODS: We investigated the cognitions associated with chest pain of three patient groups: proven symptomatic coronary artery disease (CAD+), subjects with chest pain and a normal coronary angiogram (CAD-), and patients with panic disorder (PD). All patients were classified according to whether the symptomatology was, firstly, associated with frightening cognitions (during the episode), and, secondly, whether either these cognitions (cognitive predominance), or the physical symptom (physical predominance), dominated the clinical picture.
RESULTS: We observed that in the CAD+ group, 18% experienced frightening cognitions but in only 4% (2 of 66 patients) were the cognitions the dominant experience during the chest pain. In contrast, all the PD patients experienced frightening cognitions and in 83% of this group, the cognitions were the predominant experience. In the CAD- group, 48% were found to be PD compatible.
CONCLUSIONS: This study indicates that the cognitions of patients during episodes of chest pain, evaluated by three questions, help to differentiate between PD and true coronary symptoms. Consequently, the presence of frightening cognitions in the presence of chest pain, particularly at the onset of the clinical problem, makes necessary the need for psychiatric evaluation with the objective of excluding PD.
METHODS: We investigated the cognitions associated with chest pain of three patient groups: proven symptomatic coronary artery disease (CAD+), subjects with chest pain and a normal coronary angiogram (CAD-), and patients with panic disorder (PD). All patients were classified according to whether the symptomatology was, firstly, associated with frightening cognitions (during the episode), and, secondly, whether either these cognitions (cognitive predominance), or the physical symptom (physical predominance), dominated the clinical picture.
RESULTS: We observed that in the CAD+ group, 18% experienced frightening cognitions but in only 4% (2 of 66 patients) were the cognitions the dominant experience during the chest pain. In contrast, all the PD patients experienced frightening cognitions and in 83% of this group, the cognitions were the predominant experience. In the CAD- group, 48% were found to be PD compatible.
CONCLUSIONS: This study indicates that the cognitions of patients during episodes of chest pain, evaluated by three questions, help to differentiate between PD and true coronary symptoms. Consequently, the presence of frightening cognitions in the presence of chest pain, particularly at the onset of the clinical problem, makes necessary the need for psychiatric evaluation with the objective of excluding PD.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app